The combined serum levels of<i>miR-375</i>and urokinase plasminogen activator receptor are suggested as diagnostic and prognostic biomarkers in prostate cancerSven Wach, Helge Täubert, Verena Huppert et al.|International Journal of Cancer|2015Cited by 53
Exploring the MIR143-UPAR Axis for the Inhibition of Human Prostate Cancer Cells In Vitro and In VivoSven Wach, Achim Aigner, Madeleine Brandl et al.|Molecular Therapy — Nucleic Acids|2019Cited by 30
Association of Tissue mRNA and Serum Antigen Levels of Members of the Urokinase-Type Plasminogen Activator System with Clinical and Prognostic Parameters in Prostate CancerOmar Al‐Janabi, S. Füssel, Helge Täubert et al.|BioMed Research International|2014Cited by 18
Abstract 39: Expression of uPA-system members correlate with the clinico-pathological parameters of PCa patientsOmar Al‐Janabi, S. Füssel, Helge Täubert et al.|Cancer Research|2014Cited by 0
Abstract 4683: Correlation of transcript levels of members of the urokinase-type plasminogen activator system with clinico-pathological parameters in prostate cancer .Omar Al‐Janabi, Susanne Fuessel, Helge Täubert et al.|Cancer Research|2013Cited by 0